Site updated at Wednesday, 22 June 2016

Living with Dementia


Groups convince FDA to ease Alzheimer’s trial rules

Academic and industry experts said on Tuesday they have convinced U.S. regulators to ease safety restrictions imposed on clinical trials of Alzheimer’s drugs, a move that could improve the chances that a drug being developed jointly by Pfizer and Johnson & Johnson might succeed.

A 2008 study of 240 patients testing that drug, known… Groups convince FDA to ease Alzheimer’s trial rules   

Living with dementia

korsakoff psychosis11 - cognitive problems2 - mental confusion4 - guv membrane1 - socioeconomic boundaries1 - dopamine6 - cancer1 - pd dementia1 - archives of general psychiatry1 - inflammatory process1 - parkinsons diagnosis1 - amyloid-beta4 - risk of stroke1 - brain functions in patients1 - β-amyloid1 - stroke risk1 - behavioral problems1 - apolipoprotein e41 - novel proteins1 - memory problems3 - beta amyloid protein1 - hormone replacement therapy1 - dementias first signs1 - quantitative structural neuroimaging1 - general anesthesia1 - neocortex1 - cognitive testing2 - cognitive changes1 - haloperidol2 - types of dementia2 -